Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use Sorafenib + 5-FU to evaluate activity, efficacy, safety,
pharmacodynamics (PD) and pharmacokinetics (PK) in patients with advanced hepatocellular
carcinoma (HCC).